Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of ...

From penile cancer to oropharyngeal cancer, know the health risks of HPV for men’s health. The expert emphasised on the need ...

HPV isn't just a concern for women — it’s actually more common in men and is driving a rise in dangerous cancers, including ...

In fact, HPV does cause more than 9 out of every 10 cases of cervical cancer, but the virus also causes cancers of the penis, ...

Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...

Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus ...

A new survey released today by The Ohio State University Comprehensive Cancer Center highlights significant misconceptions ...

OVER a quarter of schoolkids are missing out on a vital vaccine that protects against six cancers, health bosses have warned.

A recent study published in JAMA Oncology presents promising new data on a treatment regimen beneficial to patients with a subset of head and neck cancer k | Cancer ...

We are thrilled to share that the first trial site has been initiated and activation of additional clinical sites continues,” said Frank Bedu-Addo, PhD, President and Chief Executive Officer of PDS ...

As new research shows the number of teenagers having the HPV vaccine has dropped, a charity warns of a 'worrying lack of ...

PDS Biotechnology (PDSB) announced the initiation of the VERSATILE-003 Phase 3 clinical trial. The trial is now open to patient enrollment.